共 82 条
[1]
Yamada K(2022)Characteristics of anal canal cancer in Japan Cancer Med 11 2735-2743
[2]
Saiki Y(1997)Sexually transmitted infection as a cause of anal cancer N Engl J Med 337 1350-1358
[3]
Komori K(2021)Association of subjective health and abnormal cervical cytology in Japanese pregnant women: an adjunct study of the Japan Environment and Children’s Study Prev Med Rep 24 4344-4351
[4]
Shiomi A(2012)Long-term update of US GI intergroup RTOG 98–11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin J Clin Oncol 30 516-524
[5]
Ueno M(2013)Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial Lancet Oncol 14 1941-1948
[6]
Ito M(2012)Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER Accord 03 trial J Clin Oncol 30 861-865
[7]
Frisch M(1999)Carcinome épidermoïde métastatique de l’anus: étude rétrospective de l’efficacité de l’association de 5-fluoro-uracile en perfusion continue et de cisplatin Bull Cancer 86 1094-1106
[8]
Glimelius B(2018)Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study Lancet Oncol 19 2510-2518
[9]
van den Brule AJ(2020)International rare cancers initiative multicenter randomized Phase II trial of cisplatin and fluorouracil versus carboplatin and paclitaxel in advanced anal cancer: InterAAct J Clin Oncol 38 2294-2302
[10]
Wohlfahrt J(2015)Anal cancer treatment: current status and future perspectives World J Gastroenterol 21 1129-1136